4D Molecular Therapeutics, Inc. (FDMT) — Analyst estimates
Consensus analyst estimates for 4D Molecular Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 3.20M | -0.96 | 1 |
| 2027 | 15.18M | -3.72 | 5 |
| 2028 | 41.43M | -3.67 | 4 |
| 2029 | 137.08M | -3.01 | 2 |
| 2030 | 295.86M | -1.91 | 2 |
Consensus analyst estimates by fiscal year.